These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 23992005

  • 1. Clinical observations on the association between diagnosis of lung cancer and serum tumor markers in combination.
    Wang WJ, Tao Z, Gu W, Sun LH.
    Asian Pac J Cancer Prev; 2013; 14(7):4369-71. PubMed ID: 23992005
    [Abstract] [Full Text] [Related]

  • 2. Clinical utility of haptoglobin in combination with CEA, NSE and CYFRA21-1 for diagnosis of lung cancer.
    Wang B, He YJ, Tian YX, Yang RN, Zhu YR, Qiu H.
    Asian Pac J Cancer Prev; 2014; 15(22):9611-4. PubMed ID: 25520076
    [Abstract] [Full Text] [Related]

  • 3. The important role of circulating CYFRA21-1 in metastasis diagnosis and prognostic value compared with carcinoembryonic antigen and neuron-specific enolase in lung cancer patients.
    Zhang L, Liu D, Li L, Pu D, Zhou P, Jing Y, Yu H, Wang Y, Zhu Y, He Y, Li Y, Zhao S, Qiu Z, Li W.
    BMC Cancer; 2017 Feb 02; 17(1):96. PubMed ID: 28152979
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China.
    Ma L, Xie XW, Wang HY, Ma LY, Wen ZG.
    Asian Pac J Cancer Prev; 2015 Feb 02; 16(12):4891-4. PubMed ID: 26163610
    [Abstract] [Full Text] [Related]

  • 6. The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited.
    Ma S, Shen L, Qian N, Chen K.
    Cancer Biomark; 2015 Feb 02; 10(3-4):155-62. PubMed ID: 22674301
    [Abstract] [Full Text] [Related]

  • 7. The reference intervals for CA125, CA15-3, CA19-9, CA72-4, AFP, CEA, NSE and CYFRA21-1.
    Yang J, Tang A, Ma J, Sun X, Ming L.
    Scand J Clin Lab Invest; 2019 Feb 02; 79(1-2):71-74. PubMed ID: 30727773
    [Abstract] [Full Text] [Related]

  • 8. Combined detection of estrogen and tumor markers is an important reference factor in the diagnosis and prognosis of lung cancer.
    Bai Y, Shen W, Zhu M, Zhang L, Wei Y, Tang H, Zhao J.
    J Cell Biochem; 2019 Jan 02; 120(1):105-114. PubMed ID: 30216488
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Determination of the best prognostic value of serum tumor markers in patients with suspected lung cancer in an Iranian population.
    Sigari N, Mohsenpour B, Nikkhoo B, Ghaderi B, Afkhamzadeh A, Azadi NA, Fathi F, Abdi M.
    Clin Lab; 2014 Jan 02; 60(1):23-7. PubMed ID: 24600971
    [Abstract] [Full Text] [Related]

  • 11. [Clinical Significance of Tumor Marker Detection in Patients 
with Advanced Squamous Cell Carcimoma of the Lung].
    Liang P, Li J.
    Zhongguo Fei Ai Za Zhi; 2016 Oct 20; 19(10):641-647. PubMed ID: 27760591
    [Abstract] [Full Text] [Related]

  • 12. The Serum Tumor Markers in Combination for Clinical Diagnosis of Lung Cancer.
    Wu H, Wang Q, Liu Q, Zhang Q, Huang Q, Yu Z.
    Clin Lab; 2020 Mar 01; 66(3):. PubMed ID: 32162867
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients.
    Dal Bello MG, Filiberti RA, Alama A, Orengo AM, Mussap M, Coco S, Vanni I, Boccardo S, Rijavec E, Genova C, Biello F, Barletta G, Rossi G, Tagliamento M, Maggioni C, Grossi F.
    J Transl Med; 2019 Mar 08; 17(1):74. PubMed ID: 30849967
    [Abstract] [Full Text] [Related]

  • 15. Prediction of Pleural Invasion in Challenging Non-Small-Cell Lung Cancer Patients Using Serum and Imaging Markers.
    Zhu K, Chen L, He C, Lang Y, Kong X, Qu C, Xu S.
    Dis Markers; 2020 Mar 08; 2020():6430459. PubMed ID: 32089756
    [Abstract] [Full Text] [Related]

  • 16. Biomarkers in the lung cancer diagnosis: a clinical perspective.
    Li X, Asmitananda T, Gao L, Gai D, Song Z, Zhang Y, Ren H, Yang T, Chen T, Chen M.
    Neoplasma; 2012 Mar 08; 59(5):500-7. PubMed ID: 22668014
    [Abstract] [Full Text] [Related]

  • 17. Retrospective Study to Determine Diagnostic Utility of 6 Commonly Used Lung Cancer Biomarkers Among Han and Uygur Population in Xinjiang Uygur Autonomous Region of People's Republic of China.
    Yang-Chun F, Min F, Di Z, Yan-Chun H.
    Medicine (Baltimore); 2016 May 08; 95(18):e3568. PubMed ID: 27149479
    [Abstract] [Full Text] [Related]

  • 18. The Application Value of Serum HE4 in the Diagnosis of Lung Cancer.
    Wang Y, Wang Z, Ding Y, Sun F, Ding X.
    Asian Pac J Cancer Prev; 2019 Aug 01; 20(8):2405-2407. PubMed ID: 31450913
    [Abstract] [Full Text] [Related]

  • 19. An evaluation of the tumour markers, carcinoembryonic antigen (CEA), cytokeratin marker (CYFRA 21-1) and neuron-specific enolase (NSE) in the differentiation of malignant from benign solitary pulmonary lesions.
    Seemann MD, Beinert T, Fürst H, Fink U.
    Lung Cancer; 1999 Dec 01; 26(3):149-55. PubMed ID: 10598925
    [Abstract] [Full Text] [Related]

  • 20. The concentration of CYFRA 21-1, NSE and CEA in cerebro-spinal fluid can be useful indicators for diagnosis of meningeal carcinomatosis of lung cancer.
    Wang P, Piao Y, Zhang X, Li W, Hao X.
    Cancer Biomark; 2013 Dec 01; 13(2):123-30. PubMed ID: 23838141
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.